
Groundbreaking Leukemia Treatment ‘a Whole New Approach’ to Fighting Cancer
Michigan Medicine is the only treatment center in Michigan and one of several dozen sites in the country to offer CAR T-cell immune-therapy for treating childhood leukemia.
Michigan Medicine is the only treatment center in Michigan and one of several dozen sites in the country to offer CAR T-cell immune-therapy for treating childhood leukemia.
How a new research initiative is empowering U-M physician-scientists to fight DIPG, one of the deadliest brain cancers, in innovative ways.
A multidisciplinary meeting at Mott elevates pediatric cancer cases to dozens of experts. A new review finds it’s improving care and comforting families in the process.
The marriage of immune science and cancer research may improve survival rates for some individuals with rare cancers. A groundbreaking U-M scientist explains more.
More than half of children saw either partial or complete cancer remission in an international clinical trial — an "extraordinary success."
Children with brain tumors have had limited treatment options in the past compared with adults. A new research model brings new hope.